Centene (CNC) is a publicly traded Healthcare sector company. As of July 5, 2026, CNC trades at $67.86 with a market cap of $33.51B and a P/E ratio of -5.20. CNC moved -1.39% today. Year to date, CNC is +64.67%; over the trailing twelve months it is +100.89%. Its 52-week range spans $25.08 to $69.29. Analyst consensus is buy with an average price target of $60.29. Rallies surfaces CNC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Elevance Health’s Unpopular Move Sparks 0.41% Surge as Centene Drops 0.72%: Centene’s shares fell 0.72% while Elevance Health climbed 0.41% following Elevance’s execution of a controversial strategic move that preceded its rally. Peer insurers CVS Health, Humana and UnitedHealth saw declines of 0.09%, 3.09% and 0.28%, respectively, highlighting the market’s focus on Elevance’s decision.
| Metric | Value |
|---|---|
| Price | $67.86 |
| Market Cap | $33.51B |
| P/E Ratio | -5.20 |
| EPS | $-13.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $69.29 |
| 52-Week Low | $25.08 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $198.10B |
| Net Income | $-6.45B |
| Gross Margin | 7.36% |
18 analysts cover CNC: 0 strong buy, 7 buy, 10 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $60.29.